Nifty Pharma Gains 1.16% as Large Caps Lead Advance
MarketPulse Summary: Nifty Pharma rose 1.16% (311.05 points) to 27,021.15. Breadth was positive with 71 of 130 stocks advancing against 58 declining. Large caps outperformed, with the top 10 by market capitalization averaging 1.54% versus 0.78% for smaller stocks; Mankind Pharma gained 5.96% and Laurus Labs 3.25%.
📊 Key Numbers
📈 Sector Performance
| Metric | Value |
|---|---|
| Index Level | 27,021.15 |
| Previous Close | 26,710.10 |
| Change | +1.16% |
| Change Points | 311.05 |
🎯 What drove the move?
Market reports provided contextual factors around the sector move, but the available evidence does not establish a single confirmed catalyst.
📊 Market Breadth
Across the broader Pharma stock universe used in this analysis, 58 of 130 stocks declined, while 71 advanced and 1 remained unchanged. Decliners represented 44.62%, compared with 54.62% for advancers. The breadth score was 10.00, indicating positive internal conditions. This universe should not be treated as the official index constituent universe unless separately verified.
| Category | Stocks | Share |
|---|---|---|
| Advancing | 71 | 54.62% |
| Declining | 58 | 44.62% |
| Unchanged | 1 | — |
| Breadth Score | 10.00 | |
🏢 Large Caps vs Smaller Stocks
The top 10 companies by market capitalization averaged 1.54%, while smaller stocks averaged 0.78%. The market-cap-weighted change was 1.10%, compared with a median change of 0.21% and a simple average of 0.84%. The leadership condition was large caps outperforming. The divergence indicates that the magnitude of the sector move was concentrated in larger companies.
🚀 Top Gainers
| Stock | LTP | % |
|---|---|---|
|
AHCL
Anlon Healthcare Limited
|
₹26.24 | +14.59% |
|
ZOTA
Zota Health Care LImited
|
₹1,287.80 | +12.52% |
|
TARSONS
Tarsons Products Limited
|
₹341.30 | +11.50% |
|
KPL
Kwality Pharmaceuticals Limited
|
₹3,844.90 | +10.77% |
|
ORCHPHARMA
Orchid Pharma Limited
|
₹1,081.80 | +9.31% |
📉 Top Losers
| Stock | LTP | % |
|---|---|---|
|
VAISHALI
Vaishali Pharma Limited
|
₹8.24 | -6.26% |
|
LASA
Lasa Supergenerics Limited
|
₹5.89 | -5.00% |
|
MANGALAM
Mangalam Drugs And Organics Limited
|
₹32.66 | -4.67% |
|
BROOKS
Brooks Laboratories Limited
|
₹59.09 | -3.97% |
|
VINEETLAB
Vineet Laboratories Limited
|
₹35.54 | -3.37% |
🏦 Largest Companies
Among the top gainers, Anlon Healthcare Limited gained 14.59% to 26.24, Zota Health Care LImited gained 12.52% to 1,287.80, Tarsons Products Limited gained 11.50% to 341.30. On the losing side, Vaishali Pharma Limited fell 6.26% to 8.24, Lasa Supergenerics Limited fell 5.00% to 5.89, Mangalam Drugs And Organics Limited fell 4.67% to 32.66. Among the largest companies, Sun Pharmaceutical Industries Limited gained 1.72%, Divi's Laboratories Limited gained 0.38%, Torrent Pharmaceuticals Limited gained 2.69%, Zydus Lifesciences Limited gained 0.09%, Cipla Limited declined 0.60%. The available research does not establish specific reasons for individual stock moves.
| Stock | Market Cap | LTP | % |
|---|---|---|---|
|
SUNPHARMA
Sun Pharmaceutical Industries Limited
|
4,60,672cr | ₹1,868.90 | +1.72% |
|
DIVISLAB
Divi's Laboratories Limited
|
2,45,266cr | ₹9,410.50 | +0.38% |
|
TORNTPHARM
Torrent Pharmaceuticals Limited
|
1,92,086cr | ₹4,970.00 | +2.69% |
|
ZYDUSLIFE
Zydus Lifesciences Limited
|
1,18,803cr | ₹1,161.00 | +0.09% |
|
CIPLA
Cipla Limited
|
1,14,999cr | ₹1,386.10 | -0.60% |
|
LAURUSLABS
Laurus Labs Limited
|
1,04,740cr | ₹2,017.50 | +3.25% |
|
LUPIN
Lupin Limited
|
99,295cr | ₹2,124.50 | +1.99% |
|
MANKIND
Mankind Pharma Limited
|
98,413cr | ₹2,437.80 | +5.96% |
|
DRREDDY
Dr. Reddy's Laboratories Limited
|
98,325cr | ₹1,198.30 | +1.12% |
|
AUROPHARMA
Aurobindo Pharma Limited
|
94,667cr | ₹1,713.40 | -1.19% |
📝 What the data suggests
Large Caps Drive Pharma
The data shows positive internal sector conditions. The relationship between breadth, large-cap performance and smaller-stock performance should be considered when interpreting the move.
👀 What to watch next
The divergence between large-cap and smaller stocks remains relevant to the sector's internal structure. The large caps drive pharma remains the key data-supported theme.
📊 Track Live Markets
Real-time Nifty data, sector performance, market breadth, stock movers and AI-powered analysis.
Open Dashboard →Data generated at 21 Sept 2026. Not investment advice.